nested PCR

The Ultra's combination of a lower limit of detection and ability to find dead bacilli after starting TB therapy vastly improves sensitivity compared to other tests, the study’s authors said.

Cepheid today unveiled a slew of innovations that it is developing for its flagship GeneXpert platform to help it move beyond infectious disease diagnostics and increase its presence in the oncology, epidemiology, and biodefense markets.